Literature DB >> 1330898

The comparative role of 1,25-dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line.

M Hewison1, A Brennan, R Singh-Ranger, J C Walters, D R Katz, J L O'Riordan.   

Abstract

The active metabolite of cholecalciferol, 1,25-dihydroxycholecalciferol (1,25-DHCC), is a mononuclear phagocyte product with immunoregulatory properties which can influence not only surrounding T cells but also other mononuclear phagocytes; and which acts in an autocrine fashion. In this study we have used the U937 cell line as a starting point model to investigate further the comparative role of 1,25-DHCC and phorbol myristate acetate (PMA) upon growth, differentiation and phenotype in the mononuclear phagocyte system, and have correlated our findings with changes in 1,25-DHCC metabolism and receptor expression. Both 1,25-DHCC and PMA inhibit growth and differentiate U937 cells in a dose-dependent fashion. When used together, however, at low doses of PMA, 1,25-DHCC protects against the PMA-induced growth inhibition. At high concentrations of both compounds there is a decrease (1,25-DHCC) or an increase (PMA) in 1,25-DHCC receptor expression, with either 24-OHase (1,25-DHCC) or 1-OHase (PMA) synthesis. If the compounds are used in combination the receptor levels are equivalent to controls, and both enzymes are produced. The phenotype of the 1,25-DHCC-induced cells shows light adherence, class I+, increase in CD4 and CD14 and decrease in CD71. The PMA-induced cell is tightly adherent, class I+, and strongly positive for CD13 with a concomitant decrease in both CD4 and CD71. These findings suggest another role for 1,25-DHCC in the mononuclear phagocyte system, as a potential mitogenic agent. They also suggest that 1,25-DHCC may act at both membrane and nuclear levels within this model of the mononuclear phagocyte pathway and demonstrate one possible way in which physiological peripheral macrophage heterogeneity might be induced, i.e. due to the nature of the signals which are implicated during differentiation. The presence of increased CD4 and decreased CD13 on the surface of 1,25-DHCC-differentiated cells, and vice versa on PMA-differentiated cells, illustrates how this may then be reflected in functional mononuclear phagocyte heterogeneity, which may in turn be reflected in differential peripheral function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330898      PMCID: PMC1421610     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.

Authors:  J D Nunn; D R Katz; S Barker; L J Fraher; M Hewison; G N Hendy; J L O'Riordan
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

2.  Vascular effects of cyclosporine A in vivo and in vitro.

Authors:  G Ferns; M Reidy; R Ross
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Towards a better definition of human leucocyte surface molecules.

Authors:  W Knapp; P Rieber; B Dörken; R E Schmidt; H Stein; A E vd Borne
Journal:  Immunol Today       Date:  1989-08

4.  1,25-dihydroxyvitamin D3 induces responsiveness to the chemotactic peptide f-Met-Leu-Phe in the human monocytic line U937: dissociation between calcium and oxidative metabolic responses.

Authors:  B S Polla; G Werlen; M Clerget; D Pittet; M F Rossier; A M Capponi
Journal:  J Leukoc Biol       Date:  1989-05       Impact factor: 4.962

5.  Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester.

Authors:  P R Clapham; R A Weiss; A G Dalgleish; M Exley; D Whitby; N Hogg
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

6.  Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells.

Authors:  M Hewison; S Barker; A Brennan; J Nathan; D R Katz; J L O'Riordan
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

7.  Early regulation of c-myc mRNA by 1,25-dihydroxyvitamin D3 in human myelomonocytic U937 cells.

Authors:  R Karmali; A K Bhalla; S M Farrow; M M Williams; S Lal; P M Lydyard; J L O'Riordan
Journal:  J Mol Endocrinol       Date:  1989-07       Impact factor: 5.098

8.  A dispersed-whole cell method for the determination of androgen receptors in human skin fibroblasts.

Authors:  C Eil; M E Lippman; D L Loriaux
Journal:  Steroids       Date:  1980-04       Impact factor: 2.668

9.  Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes.

Authors:  W S May; N Sahyoun; M Wolf; P Cuatrecasas
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Modulation of myelomonocytic U937 cells by vitamin D metabolites.

Authors:  M Hewison; S Barker; A Brennan; D R Katz; J L O'Riordan
Journal:  Bone Miner       Date:  1989-03
View more
  2 in total

1.  Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol.

Authors:  P Trouillas; J Honnorat; P Bret; A Jouvet; J P Gerard
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

2.  Pseudomonas pyocyanin stimulates IL-8 expression through MAPK and NF-κB pathways in differentiated U937 cells.

Authors:  Wenshu Chai; Jia Zhang; Yan Duan; Dianzhu Pan; Wei Liu; Ying Li; Xue Yan; Baiyi Chen
Journal:  BMC Microbiol       Date:  2014-02-06       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.